NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis


You May Also Like

Trillium Therapeutics Completes Amendment to SIRPaFc License Agreement

Trillium to issue C$3 million of common shares to retire sublicense revenue sharing provisionTORONTO, ...

Athenex Appoints Randoll Sze as Chief Financial Officer

BUFFALO, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global ...